Keurig Dr Pepper Appoints Anthony DiSilvestro as CFO to Drive Financial Strategy
Written by Emily J. Thompson, Senior Investment Analyst
Source: Newsfilter
Updated: Nov 25 20250mins
- New CFO Appointment: Keurig Dr Pepper has appointed Anthony DiSilvestro as Chief Financial Officer effective immediately, bringing over 40 years of industry experience to lead the Finance and Technology organizations, which is expected to enhance the company's financial management capabilities.
- Leadership Transition: Former CFO Sudhanshu Priyadarshi will serve as a strategic advisor until April 7, 2026, ensuring a smooth transition, with DiSilvestro's appointment aimed at sustaining the company's strong business foundation and financial performance.
- Financial Team Expansion: George Lagoudakis has been promoted to Deputy CFO to oversee the successful separation and establishment of the future Beverage Co., while Jane Gelfand has expanded her role in Strategic Finance and Capital Markets, managing transaction oversight for upcoming acquisitions and separations.
- Strategic Growth Opportunities: DiSilvestro emphasized KDP's growth strategy and brand value, anticipating that his extensive M&A experience will drive the company's transformation in the beverage industry, further enhancing shareholder value.
KDP.O
$0.0000%Past 6 months
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
No Data
Powered By
Intellectia
Analyst Views on KDP
Wall Street analysts forecast KDP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for KDP is 33.60 USD with a low forecast of 24.00 USD and a high forecast of 42.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
15 Analyst Rating
9 Buy
5 Hold
1 Sell
Moderate Buy
Current: 28.330
Low
24.00
Averages
33.60
High
42.00
Current: 28.330
Low
24.00
Averages
33.60
High
42.00
Jefferies
Buy
downgrade
$41 -> $39
2025-10-29
Reason
Jefferies
Price Target
$41 -> $39
2025-10-29
downgrade
Buy
Reason
Jefferies lowered the firm's price target on Keurig Dr Pepper to $39 from $41 and keeps a Buy rating on the shares after "a largely successful" investor day getting investors to move past "errors of the original JDEP deal." The nature of the deal is tricky, as the new $7B strategic investment swaps out traditional debt with a payout structure that involves a joint venture and preferred equity, but the firm thinks the strategic rationale and accretion targets remain "sensible" and unchanged, the analyst tells investors.
Wells Fargo
Overweight
maintain
$33 -> $35
2025-10-28
Reason
Wells Fargo
Price Target
$33 -> $35
2025-10-28
maintain
Overweight
Reason
Wells Fargo raised the firm's price target on Keurig Dr Pepper to $35 from $33 and keeps an Overweight rating on the shares. The firm believes debates will remain loud as it thinks the name has much to prove. With that said, Wells argues that Keurig Dr Pepper may intrigue just a touch more after solid core results, and a fresh financing that substantially reduces debt, a combination it sees bringing forward the company's investment case several years.
Barclays
Lauren Lieberman
Equal Weight
maintain
$26 -> $30
2025-10-28
Reason
Barclays
Lauren Lieberman
Price Target
$26 -> $30
2025-10-28
maintain
Equal Weight
Reason
Barclays analyst Lauren Lieberman raised the firm's price target on Keurig Dr Pepper to $30 from $26 and keeps an Equal Weight rating on the shares following the investor day. The company's updates around financing and post-separation capital structure proved more constructive than expected, the analyst tells investors in a research note.
JPMorgan
Andrea Teixeira
Overweight
downgrade
$39 -> $36
2025-10-20
Reason
JPMorgan
Andrea Teixeira
Price Target
$39 -> $36
2025-10-20
downgrade
Overweight
Reason
JPMorgan analyst Andrea Teixeira lowered the firm's price target on Keurig Dr Pepper to $36 from $39 and keeps an Overweight rating on the shares ahead of the Q3 report on October 27. The firm trimmed estimates to reflect Keurig's international mix. It believes the stock could be range-bound for the time being.
See All Ratings
About KDP
Keurig Dr Pepper Inc. is a beverage company in North America that manufactures, markets, distributes and sells hot and cold beverages and single serve brewing systems. It has a portfolio of beverage brands, including Keurig, Dr Pepper, Canada Dry, Mott's, A&W, Penafiel, Snapple, 7UP, Green Mountain Coffee Roasters, GHOST, Clamato, Core Hydration and The Original Donut Shop, as well as the Keurig brewing system. Its U.S. Refreshment Beverages segment is a manufacturer and distributor of liquid refreshment beverages (LRBs). This segment manufactures and distributes concentrates, syrup and finished beverages of its brands and third-party brands, to third-party bottlers, distributors, retailers, and end consumers. Its U.S. Coffee segment is a manufacturer and distributor of single serve brewers, specialty coffee (including hot and iced varieties), and ready to drink (RTD) coffee. Its International segment includes sales in Canada, Mexico, the Caribbean and other international markets.
About the author
Preview
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Sigh Up to Get Intellectia Insights
What factors led to Sudhanshu Priyadarshi's resignation as CFO of KDP?
How does Anthony DiSilvestro's experience align with KDP's financial goals?
How will the appointment of Anthony DiSilvestro impact KDP's stock performance?
Will the new Keurig Coffee Collective line boost KDP's market share?